Jyotsna Nambiar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jyotsna Nambiar has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bipin Nair
School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kollam 690525, Kerala, India
3 shared publications Asoke Banerji
Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O., Kollam 690525, Kerala, India
2 shared publicationsChinchu Bose
Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O., Kollam 690525, Kerala, India
2 shared publicationsGeetha B. Kumar
Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Clappana P.O., Kollam 690525, Kerala, India
2 shared publicationsPandurangan Nanjan
School of Biotechnology, Amrita Vishwa Vidyapeetham, Amritapuri, Kollam, Kerala, India
2 shared publications- Asoke Banerji
Amrita School of Biotechnology, Amrita University, Amritapuri Campus, Clappana P.O., Kollam 690 525, Kerala, India
1 shared publication
Latest Publications
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (1) , 1-9
Probing Anticancer Molecules from Onion Peels Waste; First Synthesis and Biological Studies of a Rare Quercetin Derivative-pachypodol
Background: The constant increase in global onion production escalates the generation of onion peel waste. For instance, globally, >50 lakh tons of onion waste are generated annually. Methods: Its objectionable odor precludes its use in agriculture or disposal as landfilling presents environmental issues. Previous studies show that two major flavonoids, quercetin and its glycosides (spiraeoside), have been identified in abundance in onion waste. By utilizing the spiraeoside (quercetin-4ʹ-glucoside), a rapid synthesis of pachypodol (quercetin-3,3′,7-trimethyl ether, and a rare flavonol), an essential Ayurvedic product, has been developed and achieved. Pachypodol and analogs were studied for their ability to inhibit matrix metalloproteinase-2 and -9 (MMP-2 & 9) activity. Amongst the compounds tested, pachypodol significantly inhibited MMP-2 activity. Results: In-silico docking studies suggest that, unlike most known MMP inhibitors, pachypodol interacts selectively with MMP-2 through the residues Ile222, Tyr223, and Thr227 in a zincindependent manner. Conclusion: The experimental studies also prove that pachypodol inhibits the MMP-2 enzyme in a zinc-independent way.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 21 (1) , 1-9
Probing Anticancer Molecules from Onion Peels Waste; First Synthesis and Biological Studies of a Rare Quercetin Derivative-pachypodol
Background: The constant increase in global onion production escalates the generation of onion peel waste. For instance, globally, >50 lakh tons of onion waste are generated annually. Methods: Its objectionable odor precludes its use in agriculture or disposal as landfilling presents environmental issues. Previous studies show that two major flavonoids, quercetin and its glycosides (spiraeoside), have been identified in abundance in onion waste. By utilizing the spiraeoside (quercetin-4ʹ-glucoside), a rapid synthesis of pachypodol (quercetin-3,3′,7-trimethyl ether, and a rare flavonol), an essential Ayurvedic product, has been developed and achieved. Pachypodol and analogs were studied for their ability to inhibit matrix metalloproteinase-2 and -9 (MMP-2 & 9) activity. Amongst the compounds tested, pachypodol significantly inhibited MMP-2 activity. Results: In-silico docking studies suggest that, unlike most known MMP inhibitors, pachypodol interacts selectively with MMP-2 through the residues Ile222, Tyr223, and Thr227 in a zincindependent manner. Conclusion: The experimental studies also prove that pachypodol inhibits the MMP-2 enzyme in a zinc-independent way.
- Open Access
- 18 August 2021
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 12 (4) , 633-639
Unifloral ajwain honey ameliorates differential inhibition of matrix metalloproteinases 2 and 9 protein, cytotoxicity, and antioxidant potential
- 18 August 2021
- Published by Elsevier in Journal of Ayurveda and Integrative Medicine
- Vol. 12 (4) , 633-639
Open AccessUnifloral ajwain honey ameliorates differential inhibition of matrix metalloproteinases 2 and 9 protein, cytotoxicity, and antioxidant potential
- 1 November 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 349 (1) , 139-151
Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK
- 1 November 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 349 (1) , 139-151
Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK
- 1 July 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (13) , 3781-3787
Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9
- 1 July 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (13) , 3781-3787
Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9
- 1 October 2012
- Published by Elsevier in Molecular Pharmacology
- Vol. 82 (4) , 614-622
Anacardic Acid Inhibits the Catalytic Activity of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9
Cashew nut shell liquid (CNSL) has been used in traditional medicine for the treatment of a wide variety of pathophysiological conditions. To further define the mechanism of CNSL action, we investigated the effect of cashew nut shell extract (CNSE) on two matrix metalloproteinases, MMP-2/gelatinase A and MMP-9/gelatinase B, which are known to have critical roles in several disease states. We observed that the major constituent of CNSE, anacardic acid, markedly inhibited the gelatinase activity of 3T3-L1 cells. Our gelatin zymography studies on these two secreted gelatinases, present in the conditioned media from 3T3-L1 cells, established that anacardic acid directly inhibited the catalytic activities of both MMP-2 and MMP-9. Our docking studies suggested that anacardic acid binds into the MMP-2/9 active site, with the carboxylate group of anacardic acid chelating the catalytic zinc ion and forming a hydrogen bond to a key catalytic glutamate side chain and the C15 aliphatic group being accommodated within the relatively large S1′ pocket of these gelatinases. In agreement with the docking results, our fluorescence-based studies on the recombinant MMP-2 catalytic core domain demonstrated that anacardic acid directly inhibits substrate peptide cleavage in a dose-dependent manner, with an IC50 of 11.11 μM. In addition, our gelatinase zymography and fluorescence data confirmed that the cardol-cardanol mixture, salicylic acid, and aspirin, all of which lack key functional groups present in anacardic acid, are much weaker MMP-2/MMP-9 inhibitors. Our results provide the first evidence for inhibition of gelatinase catalytic activity by anacardic acid, providing a novel template for drug discovery and a molecular mechanism potentially involved in CNSL therapeutic action.
- 1 October 2012
- Published by Elsevier in Molecular Pharmacology
- Vol. 82 (4) , 614-622
Anacardic Acid Inhibits the Catalytic Activity of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9
Cashew nut shell liquid (CNSL) has been used in traditional medicine for the treatment of a wide variety of pathophysiological conditions. To further define the mechanism of CNSL action, we investigated the effect of cashew nut shell extract (CNSE) on two matrix metalloproteinases, MMP-2/gelatinase A and MMP-9/gelatinase B, which are known to have critical roles in several disease states. We observed that the major constituent of CNSE, anacardic acid, markedly inhibited the gelatinase activity of 3T3-L1 cells. Our gelatin zymography studies on these two secreted gelatinases, present in the conditioned media from 3T3-L1 cells, established that anacardic acid directly inhibited the catalytic activities of both MMP-2 and MMP-9. Our docking studies suggested that anacardic acid binds into the MMP-2/9 active site, with the carboxylate group of anacardic acid chelating the catalytic zinc ion and forming a hydrogen bond to a key catalytic glutamate side chain and the C15 aliphatic group being accommodated within the relatively large S1′ pocket of these gelatinases. In agreement with the docking results, our fluorescence-based studies on the recombinant MMP-2 catalytic core domain demonstrated that anacardic acid directly inhibits substrate peptide cleavage in a dose-dependent manner, with an IC50 of 11.11 μM. In addition, our gelatinase zymography and fluorescence data confirmed that the cardol-cardanol mixture, salicylic acid, and aspirin, all of which lack key functional groups present in anacardic acid, are much weaker MMP-2/MMP-9 inhibitors. Our results provide the first evidence for inhibition of gelatinase catalytic activity by anacardic acid, providing a novel template for drug discovery and a molecular mechanism potentially involved in CNSL therapeutic action.